Aurobindo Pharma share price has zoomed 4% and is presently trading at Rs 1,522.4.
Meanwhile, the BSE HEALTHCARE index is at 41,176.7 (up 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.7%) and AJANTA PHARMA (up 3.9%).
Cadila Healthcare (down 5.1%) and ALEMBIC PHARMA (down 2.6%) are among the top losers today.
Over the last one year, Aurobindo Pharma has moved up from Rs 879.1 to Rs 1,522.4, registering a gain of Rs 643.3 (up 73.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,176.7, registering a gain of 44.6% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 110.7%), GRANULES INDIA (up 110.2%) and SUVEN PHARMACEUTICALS (up 105.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,314.2 (down 0.4%).
The top losers among the BSE Sensex today are HDFC Bank (down 2.7%) and Tata Motors (down 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.
In the meantime, NSE Nifty is at 24,234.3 (down 0.5%). HDFC Bank and HDFC LIFE INSURANCE are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,314.2, registering a gain of 13,318.4 points (up 20.2%).
Aurobindo Pharma net profit grew 60.6% YoY to Rs 9,196 million for the quarter ended June 2024, compared to a profit of Rs 5,725 million a year ago. Net sales rose 10.5% to Rs 75,670 million during the period as against Rs 68,505 million in April-June 2023.
For the year ended March 2024, Aurobindo Pharma reported 64.4% increase in net profit to Rs 31,690 million compared to net profit of Rs 19,277 million during FY23. Revenue of the company grew 16.7% to Rs 290,019 million during FY24.
The current Price to earnings ratio of Aurobindo Pharma, based on rolling 12 month earnings, stands at 25.2.
Equitymaster requests your view! Post a comment on "Aurobindo Pharma Gains 4%; BSE HEALTHCARE Index Up 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!